Education
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
Aflibercept, Ixo-Vec
Neovascular Age-Related Macular Degeneration (Namd), Wet Amd
Phase III
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
Feb 26, 2025
―
Advm-022
Neovascular Age-Related Macular Degeneration
Phase II
Active Not Recruiting
Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
Sep 08, 2022
―
Aflibercept, 6E11 Vg/Eye Of Advm-022, 2E11 Vg/Eye Of Advm-022
Diabetic Macular Edema, Diabetic Retinopathy
Phase II
Completed
ADVM-022 Intravitreal Gene Therapy for DME
May 28, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Adverum Biotechnologies (ADVM) have in its pipeline
ADVM is currently developing the following drugs: Aflibercept, Ixo-Vec, Advm-022, Aflibercept, 6E11 Vg/Eye Of Advm-022, 2E11 Vg/Eye Of Advm-022. These drug candidates are in various stages of clinical development as the company works toward FDA approval.